| Bickler, Philip E |
| Completed | N/A | 13 | US | Pulse oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 05/21 | 02/22 | | |
NCT05745675: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO16) |
|
|
| Completed | N/A | 11 | US | Pulse oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 01/23 | 04/24 | | |
NCT05745662: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO17) |
|
|
| Completed | N/A | 11 | US | Pulse Oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 02/23 | 04/24 | | |
| Completed | N/A | 12 | US | Mixtures of nitrogen, air, and carbon dioxide, Radial arterial cannula | Gabi SmartCare | Hypoxia | 03/23 | 03/23 | | |
NCT06149416: SpO2 Accuracy of Noninvasive Pulse Oximeter Sensor With Motion Conditions |
|
|
| Completed | N/A | 11 | US | Experimental Masimo RD SET SpO2 Adhesive Sensors | Stryker Sustainability Solutions | Healthy, Hypoxia | 05/23 | 05/23 | | |
NCT06634693: Controlled Desaturation Study for TipTraQ SpO2 Performance Validation |
|
|
| Completed | N/A | 12 | US | | PranaQ Pte. Ltd. | Hypoxia | 10/23 | 10/23 | | |
NCT06101654: Accuracy of Evie Ring Pulse Oximeter in Profound Hypoxia |
|
|
| Completed | N/A | 11 | US | Pulse oximeter | Movano Health, University of California, San Francisco | Hypoxia | 01/24 | 01/24 | | |
NCT06142019: Pulse Oximeter Accuracy in Healthy Humans During Hypoxia |
|
|
| Recruiting | N/A | 10000 | US | Controlled desaturation (hypoxemia) | University of California, San Francisco | Hypoxia, Skin Pigmentation | 08/25 | 08/25 | | |
NCT05807464: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO18) |
|
|
| Completed | N/A | 12 | US | Pulse Oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 04/23 | 05/24 | | |
NCT05807477: Accuracy of Pulse Oximeters With Profound Hypoxia At Rest (NIHO19) |
|
|
| Completed | N/A | 12 | US | Pulse Oximeter | Nihon Kohden, University of California, San Francisco | Hypoxia | 04/23 | 05/24 | | |
NCT06459206: Accuracy of the EvieMED Ring Pulse Oximeter in Profound Hypoxia |
|
|
| Recruiting | N/A | 12 | US | Pulse oximeter | Movano Health, University of California, San Francisco | Hypoxia | 06/24 | 06/24 | | |
EquiOx, NCT05554510: Pulse Oximetry Errors in Hospitalized Patients Across Varying Skin Pigmentation |
|
|
| Recruiting | N/A | 800 | US | Observational | University of California, San Francisco, Food and Drug Administration (FDA) | Hypoxemia, Pulse Oximetry, Skin Pigment | 10/24 | 10/24 | | |
| McCluggage, Julie |
NCT03907852: Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer |
|
|
| Active, not recruiting | 1/2 | 36 | Canada, US | gavo-cel, fludarabine, cyclophosphamide, Nivolumab, Ipilimumab | TCR2 Therapeutics, Bristol-Myers Squibb | Mesothelioma, Mesothelioma, Malignant, Mesothelioma; Pleura, Mesotheliomas Pleural, Mesothelioma Peritoneum, Cholangiocarcinoma, Cholangiocarcinoma Recurrent, Ovarian Cancer, Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Metastatic, High Grade Ovarian Serous Adenocarcinoma | 11/28 | 11/28 | | |
NCT04545762: Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma |
|
|
| Recruiting | 1 | 36 | US | Fludarabine, Fludarabine 30mg/m2, Fludara, Cyclophosphamide, Cyclophosphamide 300mg/m2, Cytoxan, Endoxan, Neosar, Procytox, Revimmune, Cycloblastin, anti-CD19 CAR-T cells | C. Babis Andreadis, University of California, Davis | Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Diffuse Large B Cell Lymphoma, Small Lymphocytic Lymphoma, Transformed Lymphoma | 10/25 | 10/25 | | |
| Bokoch, Michael P |
VEGA-2, NCT06802224: The Choice of Vasopressor to Prevent Postoperative Acute Kidney Injury After Major Non-Cardiac Surgery |
|
|
| Not yet recruiting | 4 | 18000 | US | Norepinephrine, Phenylephrine | University of California, San Francisco, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Michigan, Henry Ford Health System, University of Washington, University of Texas Southwestern Medical Center, Wake Forest University Health Sciences, University of Virginia, University of Maryland, Duke University | Anesthesia, Surgery With General Anesthesia, Noncardiac Surgery, Hypotension During Surgery, Acute Kidney Injury (AKI), Myocardial Injury After Noncardiac Surgery (MINS), Vasopressor | 07/28 | 07/28 | | |
| Recruiting | 2/3 | 50 | US | Angiotensin II, Giapreza (synthetic human angiotensin II), Saline, 0.9% normal saline | University of California, San Francisco, La Jolla Pharmaceutical Company | Liver Transplant; Complications, Vasoplegia | 09/25 | 09/26 | | |
| Terminated | N/A | 175 | US | Esophageal cooling/warming device, EnsoETM, ECD - Esophageal Cooling Device, Mild hypothermia, Normothermia | University of California, San Francisco, University of Colorado, Denver, The Methodist Hospital Research Institute | Cirrhosis, End Stage Liver Disease, Acute Kidney Injury, Liver Transplant; Complications, Chronic Kidney Diseases, Hepatitis c, Hepatitis B, NASH - Nonalcoholic Steatohepatitis, Alcoholic Cirrhosis, Hepatocellular Carcinoma | 08/23 | 09/23 | | |
| Kangiszer, Gyula |
KEYNOTE F73, NCT05369000: Trial of LAVA-1207 in Patients with Therapy Refractory Metastatic Castration Resistant Prostate Cancer (mCRPC) Resistant Prostate Cancer |
|
|
| Active, not recruiting | 1/2 | 180 | Europe, US | LAVA-1207, LAVA-1207 plus Pembrolizumab | Lava Therapeutics, Merck Sharp & Dohme LLC | Metastatic Castration Resistant Prostate Cancer | 04/27 | 04/27 | | |
